Oncology & Cancer

Incidence of VTE, major bleeding high in primary CNS lymphoma

(HealthDay)—The incidence of venous thromboembolism (VTE) and major bleeding is high among patients with primary central nervous system lymphoma (PCNSL), according to a study published online June 23 in Leukemia & Lymphoma.

Medications

Safety, effectiveness of VKAs, DOACs similar in general practice

(HealthDay)—For patients receiving anticoagulants, arteriovenous events and major bleeding events do not differ for those receiving vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), according to a study ...

Cardiology

What's the best blood thinner if you have a-fib?

(HealthDay)—People with the heart condition atrial fibrillation often use blood thinners to help prevent a stroke. Now a new study suggests one of those medications might stand out as safer and more effective.

Cardiology

Study compares anticoagulants for antiphospholipid syndrome

(HealthDay)—In thrombotic antiphospholipid antibody syndrome (APS), rivaroxaban is not noninferior to dose-adjusted vitamin K antagonists (VKAs), according to a study published online Oct. 15 in the Annals of Internal Medicine.

Cardiology

Combo antithrombotic therapy increases bleeding risk

(HealthDay)—Patients with chronic coronary artery disease or peripheral artery disease treated with the combination of rivaroxaban and aspirin face a greater risk for bleeding versus patients treated with aspirin alone, ...

page 8 from 40